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Abstract
Background: As most data on hepatitis in resource-poor countries relate to urban communities, surveys in the rural
environment are necessary to determine the ‘true’ prevalence of these viral infections. We undertook a survey to
determine the prevalence of hepatitis B virus (HBV) infection in an apparently healthy rural population in the
Central African Republic (CAR).
Methods: The cross-sectional study was based on dried blood spots (DBS) from 273 people recruited in four
prefectures (Lobaye, Nana-Mambéré, Ouham and Ouaka). Eluates from DBS were tested with commercial ELISA kits
to detect markers of HBV infection. DBS were directly used for DNA extraction, followed by PCR and genotyping
based on preS/S gene sequences.
Results: The overall prevalence of HBc antibodies was 27.1% (Lobaye 29%, Nana-Mambéré 28%, Ouaka 29% and
Ouham 23%) and that of HBsAg was 10.6% (Lobaye 9%, Nana-Mambéré 9%, Ouaka 19% and Ouham 8%), with
no statistically significant difference among the surveyed communities. Nineteen sequences obtained from 74
anti-HBc-positive patients all belonged to genotype E. Risk factor analysis of HBV infection pointed to sexual
transmission of the virus.
Conclusion: The prevalence of HBV is high in rural communities in the CAR and comparable to that observed in
urban areas. In addition, genotype E is prevalent in these areas. These findings underline the importance of
instituting a programme of active HBV surveillance and vaccination of the population.
Keywords: Hepatitis B virus, HBV, Central African Republic, HBV risk factors, HBV prevalence, Rural community,
HBV genotyping
Background
Despite the availability of an effective vaccine, infection
with hepatitis B virus (HBV) remains a major worldwide
health problem: over 2 billion people have been in con-
tact with the virus, and there are 400 million chronic
carriers and 1 million deaths per year [1]. It is hyperendemic
in sub-Saharan Africa and Asia [2-5]. HBV is the type spe-
cies of the Hepadnaviridae family and is categorized into
eight genotypes (A to H) on the basis of a divergence of
more than 8% in the entire nucleotide sequence of the
viral DNA. Recently, two additional genotypes, I and J,
were tentatively proposed [6,7].
There are several routes of HBV transmission in sub-
Saharan Africa. The highest prevalence is reported in
20–40-year-olds, and horizontal transmission in early life,
as a consequence of close family contact, is the most
common route of infection [8,9]. In the Central African
Republic (CAR), E is the prevalent genotype among HBV-
infected patients, although genotypes A1, D4 and a geno-
type E and D recombinant have also been reported [10].
Most studies of the seroprevalence of HBV in the CAR
have been conducted in urban areas, mainly Bangui [10-12],
with only a few in rural areas [13,14]. In order to obtain a
more precise idea of the impact of HBV infection in rural
communities, we performed a survey in four prefectures
of the country.
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A cross-sectional study was carried out between November
2007 and April 2008. On the basis of an estimated HBsAg
prevalence of 13% and a precision of 4%, we calculated that
a minimum of 271 patients were needed. Hence, dried
blood spots (DBS) were collected as previously described
[11] from 273 apparently healthy individuals in the prefec-
tures of Ouaka (n = 48), Ouham (n = 75), Nana Mambéré
(n = 75) and Lobaye (n = 75). The inhabitants of the four
prefectures represent one tenth of the rural population of
the CAR. The area selected for sampling in each prefecture
was representative of at least half (Lobaye), a third (Nana-
Mambéré and Ouaka) and a quarter (Ouham) of the total
population. The people living in the study areas were
informed of the purpose of the study well before sample
collection. Participants were recruited on a voluntary basis.
To avoid collecting blood from several members of the
same family, donors were selected randomly from among
volunteers in each family and from among all those free
of symptoms of hepatitis. Most of the participants were
illiterate, and several socio-professional groups were repre-
sented. Once air-dried, the filter papers were sealed in plas-
tic bags, taken to the laboratory at the Institut Pasteur de
Bangui and stored at −20°C with a desiccant until testing.
A questionnaire on socio-demographic characteristics,
such as gender, age, place of residence, education, mari-
tal status, parity, socioeconomic level and sexual prac-
tices, was completed for identification of risk factors for
HBV infection. Each participant or his or her parents
signed an informed consent form and was informed about
the serology results. The study protocol was approved by
the Scientific Committee of the Faculty of Health Sciences
of the University of Bangui, CAR.
Serological tests
Blood was eluted from DBS as previously described [11].
DBS were screened with the HBsAg Version 3, anti-HBc
(total) and anti-HBc (IgM) antibody kits (Abbott-Murex
Biotech Ltd, Dartford, Kent, United Kingdom). Serological
tests were performed and interpreted according to the
manufacturer’s recommendations.
Detection of HBV DNA and HBV genotyping
DNA was extracted from the DBS with the QIAamp DNA
Blood Mini Kit (Qiagen, Venlo, Netherlands) according to
the manufacturer’s protocol. The extracted DNA was
used for PCR amplification and sequencing as previously
described [15]. Partial sequences covering the preS and
S gene regions were aligned and compared with SeqScape
v2.5 (Applied Biosystems, Nieuwerkerk, Netherlands) and
BioEdit version 7.0.9.0 [16]. Phylogenetic trees were con-
structed with MEGA4 software [17] and the neighbour-
joining and Kimura 2-parameter methods. Sequences
representative of known genotypes and sub-genotypes
and the most similar previously published sequences
identified by BLAST were downloaded from GenBank
and included in the analysis. The nucleotide sequence
data reported in this paper are available under GenBank
accession numbers JQ972779–JQ972830.
Statistical analysis
Stata 11.0 software was used to determine the prevalence
rates of HBV; the Fisher exact test was used to compare
variables and the association between HBV positivity and
risk factors such as marital status, years since first sexual
intercourse, use of condoms, number of sexual partners,
socio-professional activity and previous risk behaviour.
These risk factors of HBV infection were assessed by esti-
mating odds ratios. Confidence intervals were calculated
at 95%. Statistical significance was assessed at p < 0.05.
Results
Serology and geographical distribution of hepatitis B
virus in the four prefectures
In the tested population, comprising 173 (63.7%) females
and 100 (36.6%) males aged 2–67 years (mean, 27 years,
SD ± 15), 74 people (27.1%) had anti-HBc antibodies, in-
dicating that a high proportion of these rural populations
had been exposed to HBV. The population prevalence was
estimated as 24.2% by standardizing the seroprevalence
results obtained according to the gender and age group
distribution of the CAR population. HBsAg was found
in 29 (10.6%) donors, and 7 (24.1%) had been recently
infected or presented with acute viral hepatitis B (anti-
HBc IgM antibody positive). Five were aged 17–25 years
and two were more than 25 years old. Forty-five (16.5%)
individuals were positive for anti-HBc but negative
for HBsAg.
The prevalence of HBV infection was higher in males
than in females over 16 years of age (p = 0.03, Table 1).
Although no statistically significant differences in the
overall HBV and HBsAg prevalence in the four prefec-
tures were observed, a higher HBsAg rate was found in
Ouaka than in the other three locations (Figure 1).
Risk factors for HBV infection
No statistically significant association was found between
HBV infection and socio-demographic characteristics. How-
ever, monogamous males had a slightly higher HBV preva-
lence (40% or 16/40) than single or polygamic males (24%
or 12/49) (Table 2) (p value = 0.18). Sexual behavior (years
since first sexual intercourse, use of condoms and number
of sexual partners) was only moderately associated with
HBV infection. The only profession associated with HBV
infection was small trader (Table 2). Although the HBsAg
prevalence seems to be higher in the Ouaka prefecture than
in the three other prefectures no particular predisposing
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risk factors were identified, maybe because of the limited
number of positive people.
Sequence analysis and genotyping
Sequence information was obtained for 19 of the 74 anti-
HBc antibody-positive samples tested, with 14 sequences
from HBsAg-positive samples and 5 from people positive
only for antibodies to HBc. All the sequences belonged
to genotype E and were similar to strains from CAR,
Cameroon, Guinea and Niger (Figures 2A and 2B).
Discussion
The overall prevalence of HBV detected in the present
study was slightly higher than that reported in blood
Figure 1 Geographical location of the four surveyed prefectures and their HBsAg and HBc antibody prevalence.
















0–15 5 (29) 17.8 (3.5–31.0) 5 (28) 17.8 (3.7–32.0) 10 (57) 17.5 (8.4–32.3)
16–25 18 (40) 45.0 (29.6–60.4) 20 (58) 34.5 (22.2–46.7) 38 (98) 38.8 (27.4–53.2)
> 25 8 (31) 25.8 (10.4–41.2) 18 (87) 20.7 (12.2–29.2) 26 (18) 22.0 (14.4–32.3)
All 31 (100) 31.0 (21.1–44.0) 43 (173) 25.0 (18.0–33.5) 74 (273) 27.1** (21.3–34.0)
*At least one marker (HBsAg or anti-HBc antibody).
**The estimated population prevalence after taking into account the gender and age group distribution of the CAR is 24.2%.
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donors in Burkina Faso (14.96%) [18], lower than those
reported in pregnant women in the United Republic of
Tanzania (56.2%) [19] and in Ghana (67.1%) [20], in a
cohort of students in Bangui (42.3%) [11], in blood do-
nors in Cameroon (86.8%) and Sudan (36%) [21,22] and
in the staff of a public hospital in Luanda (79.7%) [23].
The diversity of the observed prevalence is probably
due to the diversity of patients and population groups
and differences in sampling method, test kit sensitivity
and specificity or differences between rural areas and large
cities. In large cities, population movement and a permis-
sive lifestyle increase the risk for exposure to this disease.
Dried blood spots are now commonly used for serology
and molecular biology testing. The only problem encoun-
tered so far is a slightly lower sensitivity, although reliable
results are obtained. The technique permits surveys to be
conducted in remote areas, as it requires little equipment,
the cost of sampling is low, and it is widely accepted as it
is almost painless [11].
A better estimate of the prevalence of HBV infection
in rural areas throughout the country would have been
obtained if we had surveyed all 16 prefectures; however,
this was not possible because of the absence of practic-
able roads and wide insecurity. Nevertheless, the
Table 2 Risk factors for HBV infection
Variable n *HBV+ (%) Odds ratio 95% CI
Marital status
○ Male
• Monogamous marriage 40 16 (40.0) 1.00
• Single 49 12 (24.5) 0.51 0.20–1.27
• Polygamous marriage 11 03 (27.0) 0.56 0.12–2.44
○ Female
• Monogamous marriage 81 22 (27.1) 1.00
• Single 73 16 (22.0) 0.75 0.35–1.57
• Polygamous marriage 19 05 (26.3) 0.95 0.30–2.97
Years since first sexual intercourse
○ ≤ 10 99 26 (26.3) 1.00
○ 11–20 48 17 (35.4) 1.53 0.73–3.23
○ 21–30 31 11 (35.5) 1.54 0.65–3.65
○ > 30 28 06 (21.4) 0.76 0.27–2.09
Use of condoms
○ Yes 19 06 (31.6) 1.00
○ No 227 64 (28.2) 1.12 0.40–3.10
Number of sexual partners
○ One 6 02 (33.3) 1
○ Two or more 102 32 (31.4) 1.20 0.21–6.83
Socio-professional activity
○ Civil servant 24 05 (20.8) 1.00
○ Small trader 10 05 (50.0) 3.80 0.78–18.50
○ Farmer 63 19 (30.2) 1.64 0.53–5.04
○ Student 74 22 (29.7) 1.60 0.53–4.84
○ Unemployed 28 05 (17.8) 0.80 0.20–3.28
○ Others** 65 18 (27.7) 1.45 0.47–4.48
Previous risk behaviour
○ None 71 22 (31.0) 1.00
○ Scarification 169 44 (26.0) 0.78 0.42–1.44
○ Surgery 47 12 (25.5) 0.76 0.33–1.74
○ Blood transfusion 30 04 (13.3) 0.34 0.10–1.10
○ Tattooing 31 09 (29.0) 0.91 0.36–2.29
○ Dental surgery 33 10 (30.3) 0.96 0.39–2.37
*At least one marker (HBsAg or anti-HBc antibodies).
**Others: carpenter, apprentice, driver, night watchman, craftsman.
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Figure 2 Phylogenetic tree based on 763 nucleotides of the preS (A) (13 strains) and 884 nucleotides of the S (B) (19 strains) gene
regions of HBV strains from the Central African Republic (marked with a black dot) and reference strains of recognized and proposed
genotypes and closest BLAST fits; GenBank accession numbers are indicated in the tree. Only bootstrap values (n = 1000) ≥ 70 are shown.
Komas et al. BMC Infectious Diseases 2013, 13:286 Page 5 of 7
http://www.biomedcentral.com/1471-2334/13/286
prevalences of HBV in the four prefectures studied
(Lobaye 29%, Nana-Mambéré 28%, Ouaka 29% and
Ouham 23%) are similar and lower than the only previ-
ous prevalence data published more than two decades
ago in the prefecture of Ouham-Pendé (61% in 1984 and
48% in 1988) [13]. Similarly, the HBsAg prevalence was
lower than in Ouham-Pendé (20.9%) [14] in all prefec-
tures except for Ouaka (19%, Figure 1). The high
HBsAg prevalence in Ouaka prefecture was not statis-
tically different from that in the other three prefectures,
probably because of the relatively small number of people
investigated. Individuals positive for antibodies against
HBc but HBsAg negative were found commonly (16.5%),
and viral DNA was detected in five. Thus, the number of
patients with active HBV infection is underestimated if
only HBsAg prevalence is considered. Inability to detect
HBsAg may be due to a mutation (G145R for example,
which abolishes HBsAg specificity); however, such mu-
tants are unlikely to be selected by vaccination [24],
which in the CAR is given only to young children within
the expanded programme of immunization (EPI) . A high
prevalence of HBV DNA in the absence of HBsAg was
previously described among students in Benin, which was
not explained by mutations in the S gene sequence [25],
and has also been observed previously in the CAR [10]. A
certain characteristic of the population that favours oc-
cult infection is a possibility and requires additional in-
vestigation [26]. Occult infections are often overlooked,
as these patients are considered uninfected on the basis
of HBsAg test results. As a consequence, a diagnosis of
chronic hepatitis B should systematically include screening
for HBV DNA when antibodies to HBc are present and
HBsAg is not.
Analysis of the socio-demographic data did not reveal
any significant risk factor for acquiring HBV infection in
rural areas of the CAR. Nevertheless, small traders were
more often affected than people in other professions
(50%); sexual practices (30–40%), tattooing (29%), blood
transfusion (13%) and dental surgery (10%) were other pos-
sible risk factors. These percentages were much lower than
in a cohort of students in Bangui [11] (sexual practices,
38.2–53.3%; tattooing, 42.4%; blood transfusion, 39.4%;
dental surgery; 38%). It is possible that other unknown or
unstudied risk factors contribute to the transmission of
HBV in rural CAR, and large-scale studies should be
performed, including more risk factors.
In contrast to other studies [4,21,23] that showed a
certain diversity of HBV genotypes in Central African
countries, this study confirms that genotype E is highly
predominant, not only in Bangui [10] but also in rural
areas of the CAR, supporting the hypothesis that this
country is part of the vast genotype E crescent, spanning
Africa from Senegal to Angola [25]. Characterization of
HBV nucleotide sequences from a large sampling in
rural CAR should be undertaken to better evaluate the
genetic variability of this virus in these areas.
Conclusion
HBV infection is a major health issue in the CAR, as
shown by high prevalence rates. The prevalence in the four
prefectures is close to that in Bangui, and only genotype E
sequences were found. This high prevalence confirms that
HBV is responsible for high rates of morbidity and mor-
tality in CAR. The results underline the necessity for adult
vaccination against hepatitis B in addition to HBV vaccin-
ation included in the EPI since November 2008.
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